Severe Mental Illness and Type 2 Diabetes Outcomes and Complications: A Nationwide Cohort Study

被引:18
作者
Fleetwood, Kelly J. [1 ]
Wild, Sarah H. [1 ]
Licence, Kirsty A. M. [2 ]
Mercer, Stewart W. [1 ]
Smith, Daniel J. [3 ]
Jackson, Caroline A. [1 ]
机构
[1] Univ Edinburgh, Usher Inst, Edinburgh, Scotland
[2] Natl Hlth Serv Scotland, Natl Serv Scotland, Informat Serv Div, Edinburgh, Scotland
[3] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland
基金
英国医学研究理事会;
关键词
RISK; MORTALITY; SCHIZOPHRENIA; INDIVIDUALS; DEPRESSION; PEOPLE; DISORDERS; CARE; ASSOCIATION; QUALITY;
D O I
10.2337/dc23-0177
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVETo compare cardiovascular and mortality outcomes in people with severe mental illness (SMI) versus no mental illness in a national cohort study of people with type 2 diabetes. RESEARCH DESIGN AND METHODSWe included adults diagnosed with type 2 diabetes between 2004 and 2018 from the national Scottish diabetes register, ascertaining history of mental illness from linked psychiatric and general hospital admission records. We identified major cardiovascular disease (CVD) events, all-cause mortality, and CVD-specific mortality through record linkage. Using Cox regression, we estimated hazard ratios (HRs) for associations between SMI and outcomes, adjusting for baseline sociodemographic and clinical characteristics, including history of CVD, comorbidity, hypertension, high cholesterol, HbA(1c), BMI, alcohol use disorder, and smoking. RESULTSAmong 259,875 people with type 2 diabetes, 1.0%, 0.5%, and 3.0% had schizophrenia, bipolar disorder, and major depression, respectively. After adjusting for sociodemographic characteristics, the risk of major CVD events was higher in people with schizophrenia (HR 1.22, 95% CI 1.06-1.41), bipolar disorder (HR 1.58, 95% CI 1.33-1.87), and major depression (HR 1.59, 95% CI 1.49-1.70) compared with people without a history of mental illness. SMI was also associated with an approximately twofold increased risk of CVD-specific and all-cause mortality. All associations attenuated following further adjustment for clinical characteristics. CONCLUSIONSAmong people with diabetes, people with a history of SMI have poorer cardiovascular and mortality outcomes compared with those without mental illness. While the underlying mechanisms are further investigated, effective prevention and management of cardiovascular risk factors is needed in this high-risk group.
引用
收藏
页码:1363 / 1371
页数:10
相关论文
共 40 条
[1]   Risk of developing diabetes mellitus and hyperlipidemia among patients with bipolar disorder, major depressive disorder, and schizophrenia: A 10-year nationwide population-based prospective cohort study [J].
Bai, Ya-Mei ;
Su, Tung-Ping ;
Chen, Mu-Hong ;
Chen, Tzeng-Ji ;
Chang, Wen-Han .
JOURNAL OF AFFECTIVE DISORDERS, 2013, 150 (01) :57-62
[2]   Mechanisms of insulin resistance, mitochondrial dysfunction and the action of the ketogenic diet in bipolar disorder. Focus on the PI3K/AKT/HIF1-a pathway [J].
Campbell, Iain ;
Campbell, Harry .
MEDICAL HYPOTHESES, 2020, 145
[3]   Mortality, Revascularization, and Cardioprotective Pharmacotherapy After Acute Coronary Syndrome in Patients With Severe Mental Illness: A Systematic Review and Meta-analysis [J].
Chan, Joe Kwun Nam ;
Chu, Ryan Sai Ting ;
Hung, Chun ;
Law, Jenny Wai Yiu ;
Wong, Corine Sau Man ;
Chang, Wing Chung .
SCHIZOPHRENIA BULLETIN, 2022, 48 (05) :981-998
[4]   Diabetes complication burden and patterns and risk of mortality in people with schizophrenia and diabetes: A population-based cohort study with 16-year follow-up [J].
Chan, Joe Kwun Nam ;
Wong, Corine Sau Man ;
Or, Philip Chi Fai ;
Chen, Eric Yu Hai ;
Chang, Wing Chung .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021, 53 :79-88
[5]   Diabetes as a cardiovascular risk factor: An overview of global trends of macro and micro vascular complications [J].
Dal Canto, Elisa ;
Ceriello, Antonio ;
Ryden, Lars ;
Ferrini, Marc ;
Hansen, Tina B. ;
Schnell, Oliver ;
Standl, Eberhard ;
Beulens, Joline W. J. .
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2019, 26 (2_SUPPL) :25-32
[6]   Comorbid depression and risk of cardiac events and cardiac mortality in people with diabetes: A systematic review and meta-analysis [J].
Farooqi, A. ;
Khunti, K. ;
Abner, S. ;
Gillies, C. ;
Morriss, R. ;
Seidu, S. .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2019, 156
[7]   Severe mental illness and mortality and coronary revascularisation following a myocardial infarction: a retrospective cohort study [J].
Fleetwood, Kelly ;
Wild, Sarah H. ;
Smith, Daniel J. ;
Mercer, Stewart W. ;
Licence, Kirsty ;
Sudlow, Cathie L. M. ;
Jackson, Caroline A. .
BMC MEDICINE, 2021, 19 (01)
[8]   Antidepressant and antipsychotic drug prescribing and diabetes outcomes: A systematic review of observational studies [J].
Greene, Charlotte R. L. ;
Ward-Penny, Hanna ;
Ioannou, Marianna F. ;
Wild, Sarah H. ;
Wu, Honghan ;
Smith, Daniel J. ;
Jackson, Caroline A. .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 199
[9]   Insulin Resistance in Schizophrenia [J].
Guest, Paul C. .
REVIEWS ON BIOMARKER STUDIES OF METABOLIC AND METABOLISM-RELATED DISORDERS, 2019, 1134 :1-16
[10]   Impact of severe mental illness on healthcare use and health outcomes for people with type 2 diabetes: a longitudinal observational study in England [J].
Han, Lu ;
Doran, Tim ;
Holt, Richard Ian Gregory ;
Hewitt, Catherine ;
Jacobs, Rowena ;
Prady, Stephanie Louise ;
Alderson, Sarah Louise ;
Shiers, David ;
Wang, Han-, I ;
Bellass, Sue ;
Gilbody, Simon ;
Kitchen, Charlotte Emma Wray ;
Lister, Jennie ;
Taylor, Johanna ;
Siddiqi, Najma .
BRITISH JOURNAL OF GENERAL PRACTICE, 2021, 71 (709) :E565-E573